Epidemiology, appropriateness, and cost of vancomycin use

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1200-1203

  Jarvis, William R ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DRUG COST; DRUG USE; EDUCATION PROGRAM; HOSPITAL COST; HUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; SURGICAL PATIENT;

EID: 0031954761     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520284     Document Type: Article

References (10)

1. Kunin CM, Johansen KS, Wornig AM, Daschner FD. Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 1990;12:12-20.
2. Liss RH, Batchelor ER. Economic evaluations of antibiotic use and resistance - a perspective. Report of Task Force 6. Rev Infect Dis 1987;9(suppl 3):S297-312.
3. Santell JP. Projecting future drug expenditures - 1995. Am J Health Syst Pharm 1995;52:151-63.
4. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic process guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
5. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA 1993;269:598-602.
6. Rodman DP, McKnight JT, Rogers T, Robbins M. The appropriateness of initial vancomycin dosing. J Fam Pract 1994;38:473-7.
7. Centers for Disease Control and Prevention. Recommendations for preventing spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44(RR-12):1-12.
8. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol 1996;17:356-9.
9. Garrelts JC, Worst WD, Silkey B, Gagnon S. A pharmacoeconomic model to evaluate antibiotic costs. Pharmacotherapy 1994;14:438-45.
10. Sinkowitz RL, Keyserling HI, Walker TJ, Jarvis WR. The epidemiology of vancomycin usage at a children's hospital, 1993-1995. J Pediatr Infect Dis 1997;16:485-9.